Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00074737
Status:
COMPLETED
Last Update Posted:
2014-09-18
First Post:
2003-12-19
Brief Title:
Dosing Study of Ara-CEL625Idarubicin in Refractory and Relapsed AML
Sponsor:
Eleos Inc
Organization:
Eleos Inc
Organization Data
Organization:
Eleos Inc
Class:
INDUSTRY
Study ID:
ELP1001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eleos Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None